Is Healthtech still attractive to corporate ventur...
Corporate venture capital has proven to be an essential resource for the de...
Read MoreWritten By
LSX
16 September 2020
Corporate venture capital has proven to be an essential resource for the de...
Read MoreHow healthtech is thriving during the pandemic
Read MoreHealthtech incubators and accelerators have proven to be a crucial force fo...
Read MorePresentation: Accelerating Digital Innovation within the Highly Regulated B...
Read MoreExecutive panel:The Payer-Provider perspective on digital health partnershi...
Read MoreExecutive panel: Navigating the new healthtech funding landscape
Read MoreIn the face of a more open, flexible, progressive policy to digitalisation ...
Read MoreThe rise of digital innovation presents an opportunity for Pharma to reimag...
Read MoreHow does Roche engage Digital StartUps and Innovators?
Read MoreHealth tech innovation has reached a climax over the last decade, and the l...
Read MoreInnovation and NHSX: The Transformation Agenda
Read MoreExecutive panel:Post Covid-19, is healthcare’s new normal digital?
Read MoreA collection of webinars, blogs and resources from LSX’s team and community – focused on connecting biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd